GSK vs MED · P/E 13, $103.31B cap vs rev $152.4M
GlaxoSmithKline PLC ADR (GSK) versus MEDIFAST INC (MED) — a side-by-side from cached financials, not a winner call.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
MEDIFAST INC (MED) is a personal services company listed on NYSE.
GSK does not have a complete income-statement cache yet.
Latest reported MED revenue for 2026-06-30 was $152.4M. Net income was -$5.2M. MED currently screens at market cap $125.3M.
GSK currently screens at market cap $103.31B and trailing P/E 13.5. MED currently screens at market cap $125.3M.
Not investment advice. Open the GSK and MED stock pages for the full models.
Not investment advice.